MSCI印度小盤股ETF-iShares SMIN 深 滬
等待開盤 04-02 09:30:00 美东时间
60.71
+0.750
+1.25%
華盛通- 最 高60.92
- 今 開60.26
- 成交量 31.98万股
- 最 低 60.15
- 昨 收 59.96
- 總市值 5.92亿
- 52周最高 77.1282
- 市盈率 靜 --
- 換手率 3.28%
- 52周最低 57.7758
- 委 比 0.00%
- 總股本 975.00万
- 歷史最高 80.4208
- 量 比 1.68
- 振 幅 1.28%
- 歷史最低 12.5921
- 每 手 1
- 風險率 3.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多UPDATE 1-UK's Smiths Group misses half-year revenue growth estimates amid US construction woes
UPDATE 1-UK's Smiths Group misses half-year revenue growth estimates amid US construction woes Recasts with half-year revenue miss in paragraph 1, details and background throughout March 20 (Reuters) - British engineering group Smiths Group SMIN.L fell short of half-year organic revenue growth estim
03-20 15:47
UK Stocks-Factors to watch on March 20
UK Stocks-Factors to watch on March 20 March 20 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Friday, with futures FFIc1 up 0.1%. * UNILEVER: Unilever ULVR.L is in talks to separate its food business and combine it with spice maker McCormick MKC.N in an all-stock deal that cou
03-20 13:09
India’s economy may be 22% smaller than reported, paper says
India’s economic growth over the past decade may have been significantly overstated, with the size of the economy potentially exaggerated by roughly 22%, according to a new research paper by three eco...
03-16 22:22
Smiths Group Cuts Share Capital with Fresh Buyback
Smiths Group plc ( ($GB:SMIN) ) has provided an update. Smiths Group plc has re...
03-14 01:47
BUZZ-Smiths Group falls after brokerage downgrades stock, cuts PT on growth concerns
BUZZ-Smiths Group falls after brokerage downgrades stock, cuts PT on growth concerns ** Shares of British engineering firm Smiths Group SMIN.L down 6.2% at 2,438p ** Stock is top percentage loser on the FTSE 100 .FTSE index, which is up 1% ** Exane BNP Paribas downgrades stock to "neutral" from "out
03-11 17:18
Johnson & Johnson wins FDA Fast Track status for nipocalimab in systemic lupus erythematosus
Johnson & Johnson wins FDA Fast Track status for nipocalimab in systemic lupus erythematosus Johnson & Johnson reported that the U.S. FDA granted Fast Track designation to nipocalimab as a potential treatment for adults with systemic lupus erythematosus. The designation is supported by results from
03-03 21:03
Smiths Group Seals £2 Billion Sale of Detection Unit to CVC
An update from Smiths Group plc ( ($GB:SMIN) ) is now available. Smiths Group h...
02-20 17:47
BRIEF-Nrx Pharmaceuticals (NasdaqNrxp) Announces Path To New Drug Application With Real World Data
BRIEF-Nrx Pharmaceuticals (NasdaqNrxp) Announces Path To New Drug Application With Real World Data Feb 17 (Reuters) - NRX Pharmaceuticals Inc NRXP.O : NRX PHARMACEUTICALS (NASDAQ:NRXP) ANNOUNCES PATH TO NEW DRUG APPLICATION WITH REAL WORLD DATA AND BROADER PROPOSED INDICATION FOR NRX-100 (KETAMINE)
02-17 20:28
Smiths Group Continues Share Buyback, Cancels Newly Repurchased Stock
Smiths Group plc ( ($GB:SMIN) ) has issued an update. Smiths Group plc has cont...
02-17 01:12
Smiths Group cancels newly repurchased shares in latest buyback
Smiths Group plc ( ($GB:SMIN) ) just unveiled an announcement. Smiths Group plc...
02-13 01:07
